
CAS 1378390-29-4
:3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Description:
3-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one is a synthetic organic compound characterized by its complex polycyclic structure, which includes a dibenzochromene framework. This compound features a bromoacetyl group, which introduces both halogen and carbonyl functionalities, potentially influencing its reactivity and biological activity. The presence of the bromine atom may enhance electrophilic characteristics, making it a candidate for various chemical reactions, including nucleophilic substitutions. The compound's dihydro form indicates that it has two hydrogen atoms added to the benzene rings, which may affect its stability and solubility in different solvents. Additionally, the presence of the ketone functional group suggests potential for hydrogen bonding and interactions with biological targets. Overall, this compound may exhibit interesting pharmacological properties, making it of interest in medicinal chemistry and drug development. However, specific properties such as melting point, boiling point, and solubility would require empirical data for precise characterization.
- 3-(2-bromoacetyl)-10,11-dihydro-5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
5H-Benzo[d]naphtho[2,3-b]pyran-8(9H)-one, 3-(2-bromoacetyl)-10,11-dihydro-
CAS:Formula:C19H15BrO3Purity:97%Color and Shape:SolidMolecular weight:371.22463-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
CAS:3-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-onePurity:97%Molecular weight:371.22g/mol3-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
CAS:Purity:97.0%Molecular weight:371.23001098632813-(2-Bromoacetyl)-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one
CAS:3-(2-Bromoacetyl)-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one is a synthetic compound that is used to treat hepatitis C. It is a Friedel–Crafts acylation product of acetylsalicylic acid with bromoacetic acid. The synthesis of this compound involves the use of organic solvents and strong bases, which can lead to impurities and byproducts. 3-(2-Bromoacetyl)-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one can be chiral or racemic depending on the synthesis process. This drug inhibits nucleophilic reactions and deaminates amino acids in the body by removing one of its hydrogen atoms. 3Formula:C19H15BrO3Purity:Min. 95%Molecular weight:371.22 g/mol




